Labcorp Holdings Inc.
As of Oct 22, 2026 close
- Market cap
- $27.05B
- P/E (TTM)
- 26.99
- Forward P/E
- 20.80
- Dividend yield
- 0.87%
- 52-week range
- $244.52$341.80
- Volume (live)
- -
- Avg. volume (3M)
- 731.12K
Labcorp Holdings (LH) Stock Price & Financial Analysis
Labcorp Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $314.78 - $331.71 |
|---|---|
| 52-Week High | $341.80 |
| 52-Week Low | $244.52 |
| Open | $320.20 |
| Volume (last close) | 961.98K |
| Average Volume (3M) | 731.12K |
| Revenue (TTM) | 14.35B |
|---|---|
| Net Income (TTM) | 1.00B |
| Free Cash Flow (TTM) | 1.16B |
| EPS (TTM) | $12.08 |
| Profit Margin | 6.99% |
| Operating Margin | 11.26% |
| Return on Equity (ROE) | 11.62% |
| Debt to Equity | 0.68 |
| Annual Dividend | $2.88 |
|---|---|
| Dividend Yield | 0.87% |
| Payout Ratio | 23.83% |
| Next Dividend Ex-Date | Nov 24, 2026 |
| Market Cap | 27.05B |
|---|---|
| Shares Outstanding | 82.00M |
| P/E Ratio (TTM) | 26.99 |
| Forward P/E | 20.80 |
| Price to Sales (P/S) | 1.89 |
| Price to Book (P/B) | 3.14 |
| EV/EBITDA | 15.10 |
| 50-Day MA | $320.46 |
|---|---|
| 200-Day MA | $284.08 |
| 1-Year Change | +16.17% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Labcorp Holdings at a Glance
As of the Oct 22, 2026 close, Labcorp Holdings (LH) has a market capitalization of $27.05B. The stock trades at 27.0× trailing earnings, 20.8× forward earnings and 1.9× sales. Over the trailing twelve months it earned $1.00B on revenue of $14.35B (a 7.0% profit margin) and generated $1.16B of free cash flow. Revenue grew 6.4% year over year.
As of its latest reported balance sheet, it holds $141.80M in cash and securities against $5.86B of debt, a net debt position of $5.72B.
Labcorp Holdings pays a quarterly dividend totaling $2.88 per share a year, a 0.87% yield at the Oct 22, 2026 close, with a 24% payout ratio.
The share price is up 16.2% over the past year. At $329.93 (the Oct 22, 2026 close) it sits near the top of its 52-week range of $244.52 to $341.80, above its 200-day moving average of $284.08.
Based on 17 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $345.00, 4.6% above the Oct 22, 2026 close.
Frequently Asked Questions About Labcorp Holdings
What is the current stock price for LH?
As of the Oct 22, 2026 close, LH stock trades at $329.93. The 52-week range is $244.52–$341.80, with a day range of $314.78–$331.71.
What is the P/E ratio for LH?
As of the Oct 22, 2026 close, Labcorp Holdings's trailing twelve-month (TTM) P/E ratio is 27.0, meaning investors pay $27.0 for every $1 of annual earnings. The forward P/E is 20.8, reflecting analyst expectations for future earnings. Labcorp Holdings operates in the Healthcare sector.
Does LH pay dividends?
Yes, Labcorp Holdings pays a 0.87% annual dividend yield as of the Oct 22, 2026 close ($2.88 per share a year). The trailing twelve-month payout ratio is 23.8%. The next ex-dividend date is November 24, 2026.
What do analysts recommend for LH?
Based on ratings from 17 professional analysts over the last 90 days, the consensus for LH is Buy. The average 12-month price target is $345.00, a 4.6% upside from the Oct 22, 2026 close of $329.93.
What is the market cap of LH?
As of the Oct 22, 2026 close, Labcorp Holdings's market capitalization is $27.05B, classifying it as a large-cap company. Labcorp Holdings operates in the Healthcare sector within the Diagnostics & Research industry.